Plantar fibromatosis (Ledderhose disease) is a rare, benign, hyperproliferative fibrous tissue disorder resulting in the formation of nodules along the plantar fascia. This condition can be locally aggressive, and often results in pain, functional disability, and decreased quality of life. Diagnosis is primarily clinical, but MRI and ultrasound are useful confirmatory adjuncts. Given the benign nature of this condition, treatment has historically involved symptomatic management. A multitude of conservative treatment strategies supported by varying levels of evidence have been described mostly in small-scale trials. These therapies include steroid injections, verapamil, radiation therapy, extracorporeal shock wave therapy, tamoxifen, and collagenase. When conservative measures fail, surgical removal of fibromas and adjacent plantar fascia is often done, although recurrence is common. This review aims to provide a broad overview of the clinical features of this disease as well as the current treatment strategies being employed in the management of this condition.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367723 | PMC |
http://dx.doi.org/10.2147/ORR.S154289 | DOI Listing |
Genes Chromosomes Cancer
September 2024
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
J Med Imaging Radiat Sci
December 2024
Department of Radiation Oncology, CancerCare Manitoba, Winnipeg, MB, Canada. Electronic address:
J Ultrasound Med
December 2024
Department of Musculoskeletal Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Cureus
July 2024
Physical Medicine and Rehabilitation, Faculty of Medicine of Oujda/Mohammed VI University Hospital of Oujda/Mohammed First University of Oujda, Oujda, MAR.
Foot Ankle Surg
January 2025
University of Northern British Columbia, 5555 University way, Prince George, BC V2N 4Z1, Canada. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!